DUBLIN, April 1, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/4c9z4z/soft_tissue ) has announced the addition of the "Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019 "report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The global soft tissue repair market is expected to reach $14.7 billion in 2019 from $10.3 billion in 2014, at a CAGR of 7.5% during the forecast period of 2014 to 2019.
Soft tissue repair products are used to repair and reconstruct soft tissue injuries. The soft tissue repair market is mainly driven by technological advancements, innovative product offerings, increasing incidence of soft tissue injuries among the aging population, increasing participation in sports, and the increasing obesity rate. However, the ambiguity in reimbursement for these products and the increasing cost of surgical procedures are expected to restrain the growth of this market in the forecast period.
Market growth will be attributed to innovative new product launches, the rising demand for soft tissue repair treatment from the aging population, increasing healthcare expenditure, and the lack of substitutes.
The soft tissue repair market studied in this report is mainly segmented by products and applications. The market, by products, is segmented into tissue patch/mesh, soft tissue fixation devices, and laparoscopic instruments. On the basis of application the market is segmented into hernia repair, dural repair, vaginal sling procedure, skin repair, orthopedic repair, dental repair, and breast reconstruction repair.
Developed geographies like North America and Europe are saturated markets and expected to grow at a slower rate, whereas the Asian market is expected to witness the highest growth due to the increasing number of soft tissue repair surgical procedures (which is caused by the rising aging population and huge patient base).
The key players operating in this market are LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex, Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Industry Insights
6 Market Overview
7 Soft Tissue Repair Market, By Product
8 Soft Tissue Repair Market, By Application
9 Soft Tissue Repair Market, By Region
10 Competitive Landscape
11 Company Profiles
- American Medical Systems Inc.
- Arthrex, Inc.
- C.R Bard, Inc.
- Covidien PLC
- Integra Lifesciences Corporation
- Johnson & Johnson
- Lifecell Corporation
- Lifenet Health, Inc.
- Smith & Nephew PLC
- Wright Medical
For more information visit http://www.researchandmarkets.com/research/4c9z4z/soft_tissue
Media Contact:Laura Wood , +353-1-481-1716, press@researchandmarkets.net
